Navigation Links
Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel® and Xerese™
Date:6/29/2011

MISSISSAUGA, Ontario, June 30, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that its subsidiary, Valeant International (Barbados) SRL (VIB), has signed an agreement to acquire rights to both Elidel (pimecrolimus 1% cream) and Xerese (acyclovir and hydrocortisone cream 5%/1%) from Meda, an international specialty pharmaceutical company (listed on Nasdaq Nordic Exchange in Stockholm) for the U.S., Canada and Mexico.  Valeant will pay Meda initial payments of approximately $76 million and over the next 18 months, will pay a series of potential milestones and royalties totaling approximately $130 million. Thereafter, Valeant will pay a long term running double digit royalty rate on net sales of Elidel, Xerese and Zovirax® including additional minimum royalties of $120 million during 2013 - 2015. Valeant has exclusive rights to Zovirax in the U.S. and Canada.  In addition, Valeant and Meda have entered into a development agreement for future life cycle management of both Elidel and Xerese. The transaction is expected to be accretive immediately.

"As previously announced, the addition of a strong worldwide brand such as Elidel is a significant enhancement to our growing North American dermatology portfolio," stated J. Michael Pearson, chairman and chief executive officer.  "The addition of Xerese, which was recently approved by the U.S. Food and Drug Administration, gives us a new strong platform for growth and will be a complementary addition to our dermatology franchise, solidifying our position as a leading dermatology company.  We believe that dermatology is an attractive therapeutic area for Valeant and will continue to look for opportunities to expand our presence with dermatologists in our key markets."

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceutic
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results
2. Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
3. Valeant Pharmaceuticals to Announce 2011 First Quarter Results on May 9, 2011
4. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
5. Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
6. Regulatory Update - GSK and Valeant Respond to FDA on ezogabine
7. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
8. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
9. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
10. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
11. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
(Date:12/22/2014)... Inc. (NASDAQ: CYBX ), a global leader in ... announced it will participate in the 33 rd  Annual ... San Francisco . Dan ... at 11:00 AM Pacific Time.  A live audio webcast of ... Relations link on the Cyberonics home page at www.cyberonics.com ...
(Date:12/22/2014)... Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies addressing ... issued the following open letter to shareholders from ... Med. Sc. Dear RXi Shareholders, ... of inaccurate statements posted on certain social media ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... Group, Inc. (NYSE: HGR ) announced today that it ... March 31, 2011, on Thursday, April 28, 2011. The ... the quarter ended March 31, 2011 on Wednesday, April 27, 2011 ... these results is scheduled to begin at 9:00 a.m., EDT, on ...
... (Pink Sheets: IMJX ), today officially reported ... highlighted the key business accomplishment during the past fiscal ... 2010 demonstrated significant improvement from 2009, with total sales ... all of 2010, both a significant improvement over the ...
Cached Medicine Technology:Hanger Orthopedic Group, Inc. Announces First Quarter 2011 Earnings Release Conference Call 2ImageXpres Posts OTC Markets 2010 Annual Report 2ImageXpres Posts OTC Markets 2010 Annual Report 3
(Date:12/25/2014)... 2014 Recently, BellasDress has ... its wedding dresses. BellasDress has chosen their best-selling lace ... choices for the holiday season. , Now, BellasDress.com ... wedding gowns here at discount prices. The business hopes ... its website. , “All our elegant products ...
(Date:12/25/2014)... When head lice hits a home or school, ... get rid of it while keeping it from taking over ... have the solution right in their neighborhood: Lice Troopers ... provides full spectrum head lice screening and treatment services to ... Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... Thompson HealthDay Reporter WEDNESDAY, ... in on a "fountain of youth" drug that can delay ... adults, a new study suggests. Seniors received a significant ... targets a genetic signaling pathway linked to aging and immune ... The experimental medication, a version of the drug rapamycin, ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 “ SmileStix ” ... which features the latest and coolest mobile applications on the ... expert and host of NewsWatch, conducted the app review and ... to create personal stickers. , The old saying goes, “A ... lot of words that can describe a single image, because ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... donor kidneys for transplantation. One solution is to increase ... ,A recent paper in the November issue of the ... kidneys, strategies that have been developed to increase the ... of the adoption of these strategies at a single ...
... atrophy, gynecomastia, and loss of sexual interest have often ... been reported in men who are long-term alcohol users,// ... of ethanol might cause gonadal disorders, including structural testicular ... of T, which might be involved in the hypogonadism ...
... diverse range of insults, such as surgery, infection and ... cell types of the immune system, creating a number ... although essential for fighting infection, may damage the host. ... and lipid mediators being the key mediators. ...
... Theodor Eich and his colleagues from University of Cologne, ... Hodgkin’s Lymphoma patients undergoing chemotherapy does not increase the ... side effects of radiation therapy. The results of the ... and Oncology. The researchers have reduced the radiation dosage ...
... both of great public health importance in tropical countries. ... malaria episodes are associated with transient increases of HIV-1 ... malaria episodes might accelerate HIV-1 disease progression and facilitate ... deleterious effects of HIV-1 infection on malaria. In pregnant ...
... Itomura and his colleagues from Toyama University, Japan have ... aggression of school children’s behavior. //Researchers have found that ... fish oil, is an important component of cell membranes ... behavior problems in boys who have lower concentrations of ...
Cached Medicine News:Health News:Strategies To Boost Living Donor Kidney Transplants 2Health News:Detrimental Effect Of Chronic Alcoholism On Male Fertility 2Health News:The ideal composition of intravenous lipid emulsion 2Health News:Malaria infection can accelerate HIV infection and disease progression 2
... The new E300 Corneal ... diverse range of clinical procedures ... Refractive Surgery and Contact Lens ... compact cone design, the E300 ...
Egg-Shaped Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be e...
... The S7 with Discrete Technology ... plus unmatched scaffolding. Proprietary Secure Technology ... proximal pillows that partially encapsulate the ... Discrete Technology is designed to minimize ...
Increased stent scaffolding at the proximal end gives optimal lumen support and 6F guide catheter compatibility and improved tracking offer excellent deliverability. Customized balloon lengths for ea...
Medicine Products: